Joining forces to find a cure and therapies for EB
EB-ResNet is a network of EB patient organisations funding EB research and partnering to drive its translation to clinical benefit.
The network aims to provide EB research information for scientists, clinicians, patients, and industry. All these stakeholders have to work closely together to achieve our overall objective: finding a cure and therapies for people living with Epidermolysis Bullosa.
EB-ResNet manages the funding of promising EB research projects worldwide on behalf of its members. It's portfolio inlcudes fundamental research up to preclinical and clinical trials. Research on Epidermolysis Bullosa has been going on since the 1980s and much has been achieved. The task now is even more challenging, as the focus is shifting to clinical translation. Join EB-ResNet, apply for funds, and share your experiences to build a partnership for clinical translation.